USPs that matters:

$kyrocking Ca$hcows

AI triggered Signals

ETF InfoDataHub

Visit our new ATH Index-Gate

White Label as a Service

Short Selling Radar

IPO InfoDataHub

2025 Survey * online * | Take part and win

Tipp: Hedge Fund Activity Tracker ("HFAT")

Info-Hub

Newswire
Directors Dealings
DD i/o
Short Selling Radar
HFAT
WWR
FTT
NewAD
Ratings
Vola-Statistics

Tools

Tools/Apps
Lab

Campus

Education
Webinars
Mentoring

Press

FAQ

What's New

Company
- About Us
- Vision/Mission
- IR
- Press
- Career
- Specials
Portfolio
Product
- CFD/FX
- Indices
- Currencies
- Commodities
- Metals
- Stocks & ETFs
- Crypto
- ETP/ETI
- Financial Innovations
Platforms
Institutional/B2B

Home
Terminal
Redcare Pharmacy NV

Redcare Pharmacy NV

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

N7975Z103

SEDOL

BYM8D77

CIK

N/A

www.redcare-pharmacy.com

LEI:

FIGI: BBG00DSX0K30

RDC

Redcare Pharmacy NV

GICS: 30101010 · Sector: - · Sub-Sector: -

PROFILER

BASIC = Free ADVANCED = User Account BUSINESS = Subscription PRIME = Subscription

ENTERPRISE = upon request

PROFILER

BASIC

ADVANCED

BUSINESS

PRIME

AI Insights

Redcare Pharmacy

Click to initiate

ENTERPRISE

NAME

Redcare Pharmacy NV

ISIN

NL0012044747

TICKER

RDC

MIC

XETR

REUTERS

RDC.DE

BLOOMBERG

SAE GR

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

X-OVR
FACTSHEET
PEERGROUP
X-News Explorer
L/S SHORT
STUDY
ROOTS
IT’s ME

FOR INVESTORS

FOR TRADERS

Securities Trading Warrants

Directors Dealings

X-Billboard

EQS Newswire

Globe Newswire

PR Newswire

BusinessWire

ACCESSWIRE

ActuNews

Newsfile

EDGAR

EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.

Thu, 09.01.2025

Redcare Pharmacy completes an exceptional year across the Group: 2024 sales up 32% to EUR 2.4bn, with Rx growth in Germany accelerating to 142% in Q4. Full-year sales increase 32% year over year to EUR 2.4bn; 21% growth in non-Rx sales to EUR 1.6bn and 64% growth in total Group Rx sales to EUR 749M. In Q4, total sales rise 27% to EUR 674M; non-...

Research & Analysis

Tue, 05.11.2024

Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October. Total Group sales growth 21% in Q3 to EUR 575M and 34% year to date to EUR 1.7bn after nine months. Non-Rx sales growth 20% in Q3 to EUR 383M (9M growth 20% to EUR 1.2bn); Rx sales growth 23%...

Research & Analysis

Thu, 03.10.2024

Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics. Q3 total Group sales up 21% year over year to EUR 574M and year to date 34% to EUR 1.7bn; non-Rx sales growth 20% year over year to EUR 383M and also 20% year to date to EUR 1.2bn. Active cus...

Research & Analysis

Thu, 03.10.2024

Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated. Sevenum, the Netherlands, 3 October 2024. The Management Board of Redcare Pharmacy has decided to intensify marketing investments for its e-Rx business in Ger...

Research & Analysis

Tue, 30.07.2024

Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin. Total sales of over EUR 1.1 bn after six months, up 42%, with Q2 year-over-year growth of 34% to EUR 561M. H1 non-Rx sales of EUR 795M (+20%); EUR 391M in Q2 (+21%). Total Rx sales of EUR...

Research & Analysis

Thu, 04.07.2024

Strong acceleration of e-Rx sales in Germany for Redcare Pharmacy, from 7% growth in Q1 to 37% in Q2. Total sales reached EUR 560M in Q2, up 33% year over year. Non-Rx sales totaled EUR 390M, steady continuation of fast growth, up 21% year over year. Rx sales increased to EUR 50M in Germany, 37% growth in Q2 year over year, while CardLink was la...

Research & Analysis

Mon, 06.05.2024

Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere. Fully digital redemption method via eGK health card and smartphone. Secure, easy and comfortable way to redeem e-prescriptions. Technically integrated within Redcare’s Shop Apotheke mobile app in Germany. Sevenum, the ...

Research & Analysis

Thu, 25.04.2024

Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany. Group sales of EUR 560M in Q1, up 51% from prior year. Non-Rx sales growth 20% to EUR 404M; Rx sales up 7% in Germany, following additional marketing and communication campaigns. Adj. EBITDA ma...

Research & Analysis

Tue, 23.04.2024

Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today. Fully digital redemption method to be integrated in Redcare’s Shop Apotheke mobile app in Germany. Expected to be available for customers by early May. Redcare ideally positioned to serve e-Rx customers in the multi-billion-euro German prescription market. Sevenum, the Neth...

Research & Analysis

Tue, 23.04.2024

Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today. Today, Redcare Pharmacy has received approval to implement its eHealth-CardLink solution from the German national agency for digital medicine, gematik. This will enable Redcare Pharmacy to offer patients in Germany a user-friendly method to redeem e-prescriptions by using thei...

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

SMART * AD

P R O D U C T S U G G E S T I O N S

Report a bug

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Page URL

Paste the page URL here

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Important note

You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .

Understood and confirmed *

I would like to continue *

Continue

Submit improvement suggestion/new feature

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

Subject *

e.g. New calculation method for Risk-of-Ruin-Calculator

View/Tool *

This view/tool

Another page/tool

Link to view/tool

View/Tool (specify URL/link)

Description of the proposed change/feedback *

The more comprehensible the description, the faster a feasibility check can be carried out.

General feedback on the view/tool/component/content *

Use this feedback text field for general or supplementary information

Would you use the tool and recommend it if necessary? *

Your opinion is valuable. Feel free to share it with us.

You are interested

Do you have a request? Get in contact with us

You are already a member?

Who is online? Community stats (Snapshot): 1.316 Visitors - 2.152 Registered members - 4 New registrations (Welcome!)

ayondo® 2024 - Est.: 2008 - Social network, community and online platform for investors with an affinity for the stock market - Business model that has won numerous international awards - Proprietary technology - Fintech pioneer and innovation driver in disruptive technologies

Made in Germany

ayondo-prime a²

Useful Links

About Us

Vision/Mission

Imprint

Legal

Data Protection

Cookie Guidelines

Privacy

Contact

MetaTrader 4

MetaTrader 5

ActivTrader

Education

Tools

Product Universe

FAQ

Visual Sitemap

Helpdesk

Fast lane

https://ayon.do/v

https://ayon.do/r

ayondo® - my community, my spirit

Social Media Links

ayondo® is a trademark of RSQ Technology Ventures GmbH ("RSQ"). RSQ is the operator of the Internet presence ayondo.com and its sub-sites. ayondo® as a brand represents a community of interest that is connected via a social network and common interests.

Financial literacy represents a key qualification. A key objective is to promote financial knowledge and financial literacy. The content published on the online portal is aimed at people who are interested in information and education in the field of investment, investing and trading and related topics. As a precautionary measure, we would like to point out that none of the content available on ayondo.com can be interpreted as a recommendation or invitation to buy or sell financial instruments, nor does it constitute any other advisory service. An explicit recommendation to use a particular service, information or financial instruments is not made.

Inasmuch as investment brokerage within the meaning of Section 2 (2) No. 3 of the German Securities Trading Act (WpIG) is provided via the online portal ayondo.com, RSQ acts as a contractually bound broker pursuant to Section 3 (2) WpIG. This service is provided exclusively for the account and under the liability of DonauCapital Wertpapier GmbH, Passauer Str. 5, 94161 Ruderting. In this case, the contractual partner of the customer is exclusively DonauCapital Wertpapier GmbH.

RSQ is entered as a contractually bound intermediary of DonauCapital Wertpapier GmbH in the public register maintained by the Federal Financial Supervisory Authority (BaFin) on the Internet. The register can be viewed at www.bafin.de.

If interested parties wish to take advantage of securities services with reference to CFD or FX trading, there is the option to consider offers from our cooperation partners for this purpose. Provided that this option is used, RSQ will broker trading accounts to the ActivTrades group of companies.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74% and 89% of all retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Consumer information

Imprint

smart.AD